Source: BioSpace

OpGen: OpGen Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q - May 24, 2024

OpGen, Inc. announced that it received a notice from The Nasdaq Stock Market LLC indicating that the Company was not in compliance with Nasdaq Listing Rule 5250 due to the Company not filing its Quarterly Report on Form 10-Q for the period ended March 31, 2024, which serves as an additional basis for delisting the Company's securities from Nasdaq, and that the Nasdaq Hearings Panel will consider this matter in connection with the continued listing of the Company's securities on Nasdaq.

Read full article »
Annual Revenue
$100K-5.0M
Employees
100-250
David E. Lazar's photo - CEO of OpGen

CEO

David E. Lazar

CEO Approval Rating

83/100

Read more